Pharma Oncology
Hydroxyurea Capsules 500mg (Avg.Fill. 629mg)
Product Overview
NGB Laboratories lists Hydroxyurea Capsules 500mg (Avg.Fill. 629mg) in its Pharma Oncology portfolio.
Product Information
- Dosage Form
- Capsule
- Therapeutic Area
- Oncology
- NGB Category
- Pharma Oncology
Product availability, specifications, regulatory status and market-specific requirements should be confirmed with NGB Laboratories.
Key Questions About Hydroxyurea Capsules 500mg (Avg.Fill. 629mg)
Does NGB Laboratories offer Hydroxyurea Capsules 500mg (Avg.Fill. 629mg)?
NGB Laboratories lists Hydroxyurea Capsules 500mg (Avg.Fill. 629mg) in its Pharma Oncology portfolio.
What presentation of Hydroxyurea Capsules 500mg (Avg.Fill. 629mg) does NGB Laboratories list?
Please contact NGB Laboratories for the current listed presentation.
What dosage form is listed for Hydroxyurea Capsules 500mg (Avg.Fill. 629mg)?
Capsule
Which therapeutic area is associated with this NGB listing?
Oncology
Related NGB Products
Explore other NGB Laboratories products in the same or a related portfolio category.
Interested in this product?
Contact NGB Laboratories for product availability and commercial enquiry.
Send Product Enquiry